BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 22722187)

  • 1. Genomics: the breast cancer landscape.
    Gray J; Druker B
    Nature; 2012 Jun; 486(7403):328-9. PubMed ID: 22722187
    [No Abstract]   [Full Text] [Related]  

  • 2. Who's driving anyway? Herculean efforts to identify the drivers of breast cancer.
    Hartmaier RJ; Priedigkeit N; Lee AV
    Breast Cancer Res; 2012 Oct; 14(5):323. PubMed ID: 23113888
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer: Genomics of metastasis.
    Gray J
    Nature; 2010 Apr; 464(7291):989-90. PubMed ID: 20393550
    [No Abstract]   [Full Text] [Related]  

  • 4. Copy number aberrations define breast cancer subgroups.
    Cancer Discov; 2012 Jun; 2(6):OF6. PubMed ID: 22684464
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The landscape of cancer genes and mutational processes in breast cancer.
    Stephens PJ; Tarpey PS; Davies H; Van Loo P; Greenman C; Wedge DC; Nik-Zainal S; Martin S; Varela I; Bignell GR; Yates LR; Papaemmanuil E; Beare D; Butler A; Cheverton A; Gamble J; Hinton J; Jia M; Jayakumar A; Jones D; Latimer C; Lau KW; McLaren S; McBride DJ; Menzies A; Mudie L; Raine K; Rad R; Chapman MS; Teague J; Easton D; Langerød A; ; Lee MT; Shen CY; Tee BT; Huimin BW; Broeks A; Vargas AC; Turashvili G; Martens J; Fatima A; Miron P; Chin SF; Thomas G; Boyault S; Mariani O; Lakhani SR; van de Vijver M; van 't Veer L; Foekens J; Desmedt C; Sotiriou C; Tutt A; Caldas C; Reis-Filho JS; Aparicio SA; Salomon AV; Børresen-Dale AL; Richardson AL; Campbell PJ; Futreal PA; Stratton MR
    Nature; 2012 May; 486(7403):400-4. PubMed ID: 22722201
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups.
    Curtis C; Shah SP; Chin SF; Turashvili G; Rueda OM; Dunning MJ; Speed D; Lynch AG; Samarajiwa S; Yuan Y; Gräf S; Ha G; Haffari G; Bashashati A; Russell R; McKinney S; ; Langerød A; Green A; Provenzano E; Wishart G; Pinder S; Watson P; Markowetz F; Murphy L; Ellis I; Purushotham A; Børresen-Dale AL; Brenton JD; Tavaré S; Caldas C; Aparicio S
    Nature; 2012 Apr; 486(7403):346-52. PubMed ID: 22522925
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Whole-genome analysis informs breast cancer response to aromatase inhibition.
    Ellis MJ; Ding L; Shen D; Luo J; Suman VJ; Wallis JW; Van Tine BA; Hoog J; Goiffon RJ; Goldstein TC; Ng S; Lin L; Crowder R; Snider J; Ballman K; Weber J; Chen K; Koboldt DC; Kandoth C; Schierding WS; McMichael JF; Miller CA; Lu C; Harris CC; McLellan MD; Wendl MC; DeSchryver K; Allred DC; Esserman L; Unzeitig G; Margenthaler J; Babiera GV; Marcom PK; Guenther JM; Leitch M; Hunt K; Olson J; Tao Y; Maher CA; Fulton LL; Fulton RS; Harrison M; Oberkfell B; Du F; Demeter R; Vickery TL; Elhammali A; Piwnica-Worms H; McDonald S; Watson M; Dooling DJ; Ota D; Chang LW; Bose R; Ley TJ; Piwnica-Worms D; Stuart JM; Wilson RK; Mardis ER
    Nature; 2012 Jun; 486(7403):353-60. PubMed ID: 22722193
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aromatase inhibitor treatment of breast cancer cells increases the expression of let-7f, a microRNA targeting CYP19A1.
    Shibahara Y; Miki Y; Onodera Y; Hata S; Chan MS; Yiu CC; Loo TY; Nakamura Y; Akahira J; Ishida T; Abe K; Hirakawa H; Chow LW; Suzuki T; Ouchi N; Sasano H
    J Pathol; 2012 Jul; 227(3):357-66. PubMed ID: 22407818
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genome remodelling in a basal-like breast cancer metastasis and xenograft.
    Ding L; Ellis MJ; Li S; Larson DE; Chen K; Wallis JW; Harris CC; McLellan MD; Fulton RS; Fulton LL; Abbott RM; Hoog J; Dooling DJ; Koboldt DC; Schmidt H; Kalicki J; Zhang Q; Chen L; Lin L; Wendl MC; McMichael JF; Magrini VJ; Cook L; McGrath SD; Vickery TL; Appelbaum E; Deschryver K; Davies S; Guintoli T; Lin L; Crowder R; Tao Y; Snider JE; Smith SM; Dukes AF; Sanderson GE; Pohl CS; Delehaunty KD; Fronick CC; Pape KA; Reed JS; Robinson JS; Hodges JS; Schierding W; Dees ND; Shen D; Locke DP; Wiechert ME; Eldred JM; Peck JB; Oberkfell BJ; Lolofie JT; Du F; Hawkins AE; O'Laughlin MD; Bernard KE; Cunningham M; Elliott G; Mason MD; Thompson DM; Ivanovich JL; Goodfellow PJ; Perou CM; Weinstock GM; Aft R; Watson M; Ley TJ; Wilson RK; Mardis ER
    Nature; 2010 Apr; 464(7291):999-1005. PubMed ID: 20393555
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Oncogenes--motors of the cancer cell].
    Schraml P
    Praxis (Bern 1994); 2004 May; 93(22):957-9. PubMed ID: 15216926
    [No Abstract]   [Full Text] [Related]  

  • 11. Identification of tumor suppressors and oncogenes from genomic and epigenetic features in ovarian cancer.
    Wrzeszczynski KO; Varadan V; Byrnes J; Lum E; Kamalakaran S; Levine DA; Dimitrova N; Zhang MQ; Lucito R
    PLoS One; 2011; 6(12):e28503. PubMed ID: 22174824
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cancer: When catastrophe strikes a cell.
    Tubio JM; Estivill X
    Nature; 2011 Feb; 470(7335):476-7. PubMed ID: 21350479
    [No Abstract]   [Full Text] [Related]  

  • 13. Evidence for a role for genomic instability in radiation-induced mutagenesis.
    Caron RM; Nagasawa H; Yu Y; Pfenning T; Vetrovs H; Little JB
    Radiat Oncol Investig; 1997; 5(3):119-23. PubMed ID: 9303068
    [No Abstract]   [Full Text] [Related]  

  • 14. Big science: The cancer genome challenge.
    Ledford H
    Nature; 2010 Apr; 464(7291):972-4. PubMed ID: 20393534
    [No Abstract]   [Full Text] [Related]  

  • 15. Genomics: The single life.
    Owens B
    Nature; 2012 Nov; 491(7422):27-9. PubMed ID: 23128208
    [No Abstract]   [Full Text] [Related]  

  • 16. Integrative deep-sequencing analysis of cancer samples: discoveries and clinical challenges.
    Roukos D
    Pharmacogenomics J; 2013 Jun; 13(3):205-8. PubMed ID: 23296155
    [No Abstract]   [Full Text] [Related]  

  • 17. Mutational evolution in a lobular breast tumour profiled at single nucleotide resolution.
    Shah SP; Morin RD; Khattra J; Prentice L; Pugh T; Burleigh A; Delaney A; Gelmon K; Guliany R; Senz J; Steidl C; Holt RA; Jones S; Sun M; Leung G; Moore R; Severson T; Taylor GA; Teschendorff AE; Tse K; Turashvili G; Varhol R; Warren RL; Watson P; Zhao Y; Caldas C; Huntsman D; Hirst M; Marra MA; Aparicio S
    Nature; 2009 Oct; 461(7265):809-13. PubMed ID: 19812674
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of candidate cancer drivers by integrative Epi-DNA and Gene Expression (iEDGE) data analysis.
    Li A; Chapuy B; Varelas X; Sebastiani P; Monti S
    Sci Rep; 2019 Nov; 9(1):16904. PubMed ID: 31729402
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aromatase and breast cancer.
    Chen S
    Front Biosci; 1998 Aug; 3():d922-33. PubMed ID: 9696881
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Micro-scale genomic DNA copy number aberrations as another means of mutagenesis in breast cancer.
    Chao HH; He X; Parker JS; Zhao W; Perou CM
    PLoS One; 2012; 7(12):e51719. PubMed ID: 23284754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.